Annual CFF
$0.00
+$7.54 M+100.00%
31 December 2023
Summary:
Greenwich LifeSciences annual cash flow from financing activities is currently $0.00, with the most recent change of +$7.54 million (+100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$2.84 million (-100.00%). GLSI annual CFF is now -100.00% below its all-time high of $29.81 million, reached on 31 December 2020.GLSI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$1.18 M
-$1.59 M-57.30%
30 September 2024
Summary:
Greenwich LifeSciences quarterly cash flow from financing activities is currently $1.18 million, with the most recent change of -$1.59 million (-57.30%) on 30 September 2024. Over the past year, it has increased by +$1.18 million (+100.00%). GLSI quarterly CFF is now -94.99% below its all-time high of $23.60 million, reached on 31 December 2020.GLSI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$4.25 M
+$1.18 M+38.53%
30 September 2024
Summary:
Greenwich LifeSciences TTM cash flow from financing activities is currently $4.25 million, with the most recent change of +$1.18 million (+38.53%) on 30 September 2024. Over the past year, it has increased by +$4.25 million (+100.00%). GLSI TTM CFF is now -86.76% below its all-time high of $32.08 million, reached on 31 March 2021.GLSI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLSI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | +100.0% |
| 3 y3 years | -100.0% | +110.0% | +49.8% |
| 5 y5 years | -100.0% | - | - |
GLSI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +100.0% | -57.3% | +121.4% | at high | +156.4% |
| 5 y | 5 years | -100.0% | +100.0% | -95.0% | +121.4% | -86.8% | +156.4% |
| alltime | all time | -100.0% | +100.0% | -95.0% | +121.4% | -86.8% | +156.4% |
Greenwich LifeSciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.18 M(-57.3%) | $4.25 M(+38.5%) |
| June 2024 | - | $2.77 M(+825.0%) | $3.07 M(+925.0%) |
| Mar 2024 | - | $299.10 K(>+9900.0%) | $299.10 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2023 | - | $0.00(0.0%) | -$2.02 M(-73.2%) |
| Dec 2022 | -$7.54 M | $0.00(0.0%) | -$7.54 M(+8.1%) |
| Sept 2022 | - | $0.00(-100.0%) | -$6.97 M(0.0%) |
| June 2022 | - | -$2.02 M(-63.3%) | -$6.97 M(+40.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$5.51 M(-1080.0%) | -$4.95 M(-274.6%) |
| Dec 2021 | $2.84 M(-90.5%) | $562.60 K(>+9900.0%) | $2.84 M(-89.0%) |
| Sept 2021 | - | $0.00(0.0%) | $25.87 M(-19.4%) |
| June 2021 | - | $0.00(-100.0%) | $32.08 M(0.0%) |
| Mar 2021 | - | $2.27 M(-90.4%) | $32.08 M(+7.6%) |
| Dec 2020 | $29.81 M(>+9900.0%) | $23.60 M(+280.2%) | $29.81 M(+380.2%) |
| Sept 2020 | - | $6.21 M(>+9900.0%) | $6.21 M(>+9900.0%) |
| June 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $215.00 K(+7.5%) | - | - |
| Dec 2018 | $200.00 K | - | - |
FAQ
- What is Greenwich LifeSciences annual cash flow from financing activities?
- What is the all time high annual CFF for Greenwich LifeSciences?
- What is Greenwich LifeSciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Greenwich LifeSciences?
- What is Greenwich LifeSciences quarterly CFF year-on-year change?
- What is Greenwich LifeSciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Greenwich LifeSciences?
- What is Greenwich LifeSciences TTM CFF year-on-year change?
What is Greenwich LifeSciences annual cash flow from financing activities?
The current annual CFF of GLSI is $0.00
What is the all time high annual CFF for Greenwich LifeSciences?
Greenwich LifeSciences all-time high annual cash flow from financing activities is $29.81 M
What is Greenwich LifeSciences quarterly cash flow from financing activities?
The current quarterly CFF of GLSI is $1.18 M
What is the all time high quarterly CFF for Greenwich LifeSciences?
Greenwich LifeSciences all-time high quarterly cash flow from financing activities is $23.60 M
What is Greenwich LifeSciences quarterly CFF year-on-year change?
Over the past year, GLSI quarterly cash flow from financing activities has changed by +$1.18 M (+100.00%)
What is Greenwich LifeSciences TTM cash flow from financing activities?
The current TTM CFF of GLSI is $4.25 M
What is the all time high TTM CFF for Greenwich LifeSciences?
Greenwich LifeSciences all-time high TTM cash flow from financing activities is $32.08 M
What is Greenwich LifeSciences TTM CFF year-on-year change?
Over the past year, GLSI TTM cash flow from financing activities has changed by +$4.25 M (+100.00%)